« Back
Home /
Mavoglurant (AFQ 056)

Mavoglurant (AFQ 056)

Item no.	DCC-DC7681-10mg
Manufacturer	DCChemicals
CASRN	543906-09-8
Amount	10 mg
Quantity options	100 mg 10 mg 25 mg
Category	Neuroscience Molecular Targets for Neuroscience Neural Signaling Reagents & Chemicals Molecules
Type	Chemicals
Specific against	other
Purity	>98%
Smiles	CC1=CC(C#C[C@]2(O)CCC[C@]3([H])[C@@]2([H])CCN3C(OC)=O)=CC=C1
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	UNII-GT0I9SV4F6; AFQ056; Mavoglurant; SureCN989279; GT0I9SV4F6; CHEMBL3087515; AFQ 056; AFQ-056
Similar products	543906-09-8
Available
Manufacturer - Applications	Mavoglurant (AFQ056) is an experimental drug candidate for the treatment of fragile X syndrome.It exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5).
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	313, 3908
Note	For research only, not for human use.
Chemical name	methyl (3aR, 4S, 7aR)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-3, 3a, 5, 6, 7, 7a-hexahydro-2H-indole-1-carboxylate

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

available

Delivery expected until 8/21/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer